Trintellix Tablet, Film Coated
Product Images NDC 55154-0256

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Trintellix (NDC 55154-0256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

86c93382 D2e2 452e B198 3ed638f5faa0 00

This appears to be prescription drug packaging information, with some general warnings and manufacturer information. The drug is called Trintellix and it should be stored at 25°C. The package includes a medication guide and the drug was manufactured in Italy. The trademark is owned by H. Lundbeck A/S and used under license by Takeda Pharmaceuticals America, Inc. The package warns against accepting it if the seal over the bottle opening is broken or missing.*

FDA Label Image

86c93382 D2e2 452e B198 3ed638f5faa0 01

This appears to be the packaging information for a medication called Trintellix, manufactured by H. Lundbeck A/S and distributed by Takeda Pharmaceuticals America, Inc. The package has storage instructions, information on dosage, and a warning to not use if the seal is broken or missing. It also advises dispensing with the accompanying medication guide and provides the contact information for the distributor, Cardinal Health.*

FDA Label Image

Figure 1 (Trintellix 01)

FDA Label Image

Figure 2 (Trintellix 02)

FDA Label Image

Figure 3 (Trintellix 03)

This text appears to be a list of different drugs and their effects on certain enzymes in the body. It includes CYP2D6 inhibitors like Buproprion, CVP inducers like Rifampin, and CYP2CORCINA inhibitors like Fluconazole. The text also mentions Omeprazole as a CYP2C19 inhibitor and the presence of Ethanol. Overall, this appears to be information for medical professionals or researchers studying drug interactions and enzyme activity in the body.*

FDA Label Image

Chemical Structure (Trintellix 04)

This appears to be a list of drugs and their interactions with various enzymes. The drugs mentioned include bupropion, omeprazole, aspirin, and ethanol. The enzymes mentioned include CYP2B6, CYP2C19, and CYP3A. However, the text is not formatted clearly and some of the characters are not readable, so it is difficult to provide a more detailed or accurate description.*

FDA Label Image

Figure 4 (Trintellix 05)

FDA Label Image

Figure 5 (Trintellix 06)

FDA Label Image

Figure 6 (Trintellix 07)

This appears to be a table related to a study or clinical trial. The drug being evaluated is TRINTELLIX aka Sorfomg, and it is being compared to a placebo. The table shows the proportion of patients with recurrence over time in weeks. However, without the full context or explanation of the study, it is difficult to provide a more detailed description or interpretation.*

FDA Label Image

Figure 7 (Trintellix 08)

FDA Label Image

Figure 8 (Trintellix 09)

FDA Label Image

Trintellix 10

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.